Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)

Open
RFA-MH-27-150Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute of Mental Health is seeking applications under solicitation RFA-MH-27-150 to establish the Rapid-Acting Psychotropic Interventional Drugs Clinical Trials Network (RAPIDs-CTN). The primary objective of this initiative is to produce real-world evidence regarding the safe and sustainable implementation of rapid-acting psychotropic interventional drugs within routine clinical settings, moving beyond controlled experimental environments. This program is specifically designed for large-scale, coordinated network projects that require a level of integration not possible through standard grant mechanisms. The funding is structured as a milestone-driven UM1 Cooperative Agreement spanning five years and divided into two distinct operational phases. Stage 1, covering the first two years, focuses on the establishment of the network and the completion of pilot studies. Stage 2, covering years three through five, is dedicated to the full-scale execution of pragmatic trials. Interested parties must submit their responses by the deadline of June 11, 2027.

General Info

NIMH seeks a five-year cooperative agreement for the RAPIDs-CTN network by June 11, 2027.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Institutes Of Health → National Institute Of Mental Health
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
This notice of funding opportunity (NOFO) encourages applications to establish a Rapid-Acting Psychotropic Interventional Drugs - Clinical Trials Network (RAPIDs-CTN). The overarching purpose is to generate actionable, real-world evidence to guide the safe and effective implementation of RAPIDs in routine clinical practice, answering urgent questions about how these treatments can be delivered sustainably outside tightly controlled experimental settings. This NOFO utilizes a milestone-driven UM1 Cooperative Agreement mechanism structured into two operational stages: Stage 1 (Years 1–2) for network establishment and pilot studies, and Stage 2 (Years 3–5) focuses for full-scale execution of proposed pragmatic trials. This program is intended only for large-scale, coordinated network projects that could not be achieved using other, more standard grant mechanisms.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
APEX Arsenal Solutions Marketplace
Solicitation # HQ0034-27-S-CAPX
The APEX Arsenal Solutions Marketplace (AASM) is a long-term open call initiated by the Department of War (DoW) Office of Industrial Base Growth, managed by the Applied Research Institute and supported by the Washington Headquarters Services Acquisition Directorate. This initiative seeks to identify and curate hardware, software, systems, and workforce development solutions that strengthen the defense industrial base and close critical capability gaps for the Warfighter. The program focuses on the development, scaling, and sustainment of emerging technologies and critical materials, making these solutions available for procurement through rapid acquisition pathways. The submission window runs from December 1, 2026, through November 30, 2027, with submissions collected in monthly cycles. Applicants must submit an unclassified .mp4 video no longer than five minutes and a completed submission form detailing their organization name, Unique Entity Identifier (UEI), and Technology Readiness Level (TRL). Submissions are evaluated by a peer panel of subject matter experts and a Government Selecting Official based on the clarity of the problem description, the strength of the proposed solution, the degree of technological advancement over current capabilities, and the viability of the business model. To maintain integrity, strict organizational conflict of interest protocols are in place, prohibiting assessors from evaluating their own technologies or those in which they hold a financial interest.
Washington Headquarters Services

POSTED

about 7 hours ago

DEADLINE

in about 1 year
View Details
NAICS: 541715
New
Federal
NSF X-Labs Initiative - Computation at the Limit of Physics
Solicitation # NSF-Topic5-FY27-XLabsComputation
The National Science Foundation (NSF) Directorate for Technology, Innovation and Partnerships is soliciting written proposals for the NSF X-Labs Initiative focusing on Computation at the Limit of Physics. This initiative seeks to develop novel platform technologies that significantly reduce the gap between the energy efficiency of conventional CMOS-based computing and inherent physical limits, such as the Landauer Limit. The goal is to achieve 4-5 orders-of-magnitude improvements in effective computational throughput per unit power through the exploration of alternative device technologies, logic frameworks, and memory technologies, including superconducting microelectronics and reversible logic. Awards will be issued as Other Transaction (OT) contracts pursuant to 42 U.S.C §19116, meaning they are not FAR-based procurement contracts or financial assistance instruments. The project is structured in phases, starting with a Phase 0 lasting 9 to 12 months beginning in October 2027, followed by a Phase 1 lasting 24 to 36 months starting in July 2028, and a variable Phase 2 for high-performing teams. Funding for Phase 1 is capped at a maximum of $1,500,000, with payments structured as quarterly milestones based on successful completion and NSF acceptance. Proposals are evaluated on two equally weighted factors: Team Qualifications and Structure, and Mission Clarity and Outcomes. The selection process is a competitive down-select involving a written proposal, followed by an invitation for an oral proposal package and presentation for selected teams. Written proposals must be submitted as a PDF of no more than 8 single-sided pages using 12-point font by March 15, 2027. Lead organizations must be registered in the System for Award Management (SAM) and provide a Unique Entity Identifier (UEI). Additionally, all proposals must include a signed Conflict of Interest statement governed by the framework of FAR Subpart 9.5 and comply with research security requirements of the CHIPS and Science Act of 2022.
Division Of Acq And Cooperative Support

POSTED

about 7 hours ago

DEADLINE

in 4 months
View Details
NAICS: 541715
New
SBIR / STTR
Ground-Based Affordable Mass (G-BAM)
Solicitation # ARM26BX04-DV010
The Ground-Based Affordable Mass (G-BAM) solicitation, issued by the U.S. Army under the U.S. Department of Defense, is a total small business set-aside opportunity utilizing a direct-to-Phase II SBIR structure. The program is designed as a three-phased effort, where Phase I typically lasts six to twelve months and Phase II generally spans 24 months. Proposals are submitted via the DSIP portal and must be organized into seven specific volumes, including technical, cost, and commercialization reports. Technical proposals must adhere to strict formatting guidelines, including a single PDF format, one-inch margins, and a minimum 10-point font, with a risk of rejection if page limits are exceeded. Award selections are based on the overall technical value and cost, with a primary focus on technical capability, innovation, and the qualifications of key personnel. Evaluation factors are prioritized by the soundness of the technical approach, the ability of the team to perform R&D and commercialize results, and the overall commercial potential for government or private sector application. To be eligible, proposing entities must be registered in the System for Award Management (SAM) and the SBA Company Registry. Additionally, contractors must comply with stringent security and legal requirements, including the Cybersecurity Maturity Model Certification (CMMC) program, Foreign Risk Evaluation (FRE), and the disclosure of any organizational conflicts of interest.
U.S. Army

POSTED

1 day ago

DEADLINE

in 13 days
View Details

More opportunities from National Institutes Of Health → National Institute Of Mental Health

Same awarding agency

NAICS: 541715
Grant
Request for Information (RFI): Strategies to Advance RAPIDs and Real-World Evidence for Serious Mental Illnesses and Related Brain Disorders
Solicitation # NOT-MH-26-090
The National Institute of Mental Health is seeking public comment and stakeholder feedback to develop strategies for building a coordinated evidence base for rapid-acting psychotropic interventional drugs (RAPIDs) used to treat serious mental illnesses and brain disorders. This Request for Information focuses on advancing real-world evidence and pragmatic clinical research to determine how these interventions, such as psilocybin and esketamine, can be delivered safely and effectively outside of tightly controlled trial environments. The goal is to establish a scalable research infrastructure, including a potential demonstration network, to harmonize data and optimize clinical practice, safety monitoring, and patient outcomes across diverse populations and care settings. NIMH is soliciting input from a wide range of stakeholders, including patients, clinicians, researchers, payers, and pharmaceutical companies, across twelve specific topic areas. These include priority effectiveness questions, pragmatic trial designs, safety protocols, delivery models, and public-private partnership strategies. This request is for planning purposes only and is not a solicitation for funding or a request for applications. Interested parties must submit their electronic responses by November 9, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS